Monoclonal antibodies - 2 News by Deutsches Krebsforschungszentrum for the biotechnology industry

Monoclonal antibodies - 2 News by Deutsches Krebsforschungszentrum for the biotechnology industry

image description

Almost two million euros for biotech start-up

BMBF funds DKFZ spin-off for the development of an antibody therapy against pancreatic cancer

12-Jun-2024 - Panosome GmbH, a biotech company founded in Heidelberg in 2020, specializes in the development of monoclonal antibodies for a wide range of medical purposes. The basis for this is the VAST technology platform jointly developed by Panosome and DKFZ. Panosome now wants to use the VAST technology to ...

monoclonal antibodies antibodies cancer

MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration with DKFZ (German Cancer Research Center)

23-Jul-2008 - MediGene AG announced that, according to plan, an option, granted two years ago by the German Cancer Research Center (Deutsches Krebsforschungszentrum = DKFZ) in Heidelberg for the development and commercialization of an antibody for the treatment of different types of cancer, including ovarian ...

monoclonal antibodies antibodies Japan

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world
Topic world Antibodies

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 26,499 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now